BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duraffour S, Malvy D, Sissoko D. How to treat Ebola virus infections? A lesson from the field. Curr Opin Virol 2017;24:9-15. [PMID: 28410486 DOI: 10.1016/j.coviro.2017.03.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Malvy D, Mcelroy AK, de Clerck H, Günther S, van Griensven J. Ebola virus disease. The Lancet 2019;393:936-48. [DOI: 10.1016/s0140-6736(18)33132-5] [Cited by in Crossref: 134] [Cited by in F6Publishing: 64] [Article Influence: 44.7] [Reference Citation Analysis]
2 Trehan I, De Silva SC. Management of Ebola Virus Disease in Children. Infect Dis Clin North Am 2018;32:201-14. [PMID: 29269191 DOI: 10.1016/j.idc.2017.10.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
3 Khan FN, Qazi S, Tanveer K, Raza K. A review on the antagonist Ebola: A prophylactic approach. Biomed Pharmacother 2017;96:1513-26. [PMID: 29208326 DOI: 10.1016/j.biopha.2017.11.103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Dhama K, Karthik K, Khandia R, Chakraborty S, Munjal A, Latheef SK, Kumar D, Ramakrishnan MA, Malik YS, Singh R, Malik SVS, Singh RK, Chaicumpa W. Advances in Designing and Developing Vaccines, Drugs, and Therapies to Counter Ebola Virus. Front Immunol 2018;9:1803. [PMID: 30147687 DOI: 10.3389/fimmu.2018.01803] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 9.5] [Reference Citation Analysis]
5 Kortepeter MG, Dierberg K, Shenoy ES, Cieslak TJ; Medical Countermeasures Working Group of the National Ebola Training and Education Center's (NETEC) Special Pathogens Research Network (SPRN). Marburg virus disease: A summary for clinicians. Int J Infect Dis 2020;99:233-42. [PMID: 32758690 DOI: 10.1016/j.ijid.2020.07.042] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Gomes MF, de la Fuente-Núñez V, Saxena A, Kuesel AC. Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials. Reprod Health 2017;14:172. [PMID: 29297366 DOI: 10.1186/s12978-017-0430-2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 7.4] [Reference Citation Analysis]
7 Kangbai JB, Heumann C, Hoelscher M, Sahr F, Froeschl G. Epidemiological characteristics, clinical manifestations, and treatment outcome of 139 paediatric Ebola patients treated at a Sierra Leone Ebola treatment center. BMC Infect Dis 2019;19:81. [PMID: 30678649 DOI: 10.1186/s12879-019-3727-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Malvy D, Sissoko D, Camara AM. [Integrating clinical research into epidemic response: the field perspective in the Ebola experience]. Med Sci (Paris) 2017;33:891-7. [PMID: 28994386 DOI: 10.1051/medsci/20173310022] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
9 Malvy D, Gaüzère BA, Migliani R. [Epidemic and emerging prone-infectious diseases: Lessons learned and ways forward]. Presse Med 2019;48:1536-50. [PMID: 31784255 DOI: 10.1016/j.lpm.2019.09.036] [Reference Citation Analysis]